Thomas K Equels
CIK 1450324 · CEO & President · last filed 2026-03-16
Thomas K Equels is a CEO & President who has filed 106 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing, for AIM, was dated Mar 16, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $25.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.9K
2
106
$1.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AIM | CEO & President | 63,922 | $0.41 | $25.9K | $401.1K | 51 | 2026-03-16 |
| AIM ImmunoTech Inc. (HEB) Delisted | Exec. Vice Chairman/CEO/Pres. | 63,041 | — | — | $678.2K | 55 | 2019-06-27 |
Recent Filings
106 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-16 | AIM | Conv (C) | +25,000 | $0 | EDGAR |
| 2026-03-10 | AIM | Other (J) | — | $0 | EDGAR |
| 2025-06-16 | AIM | Buy (P) | +107 | $824 | EDGAR |
| 2025-06-13 | AIM | Buy (P) | +103 | $896 | EDGAR |
| 2025-04-23 | AIM | Buy (P) | +1,968,504 | $50.0K | EDGAR |
| 2025-04-07 | AIM | Buy (P) | +41,000 | $2.6K | EDGAR |
| 2025-03-06 | AIM | Buy (P) | +50,000 | $6.7K | EDGAR |
| 2025-03-05 | AIM | Buy (P) | +44,000 | $5.1K | EDGAR |
| 2025-03-04 | AIM | Buy (P) | +83,334 | $10.0K | EDGAR |
| 2025-01-21 | AIM | Buy (P) | +20,000 | $4.2K | EDGAR |